These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 3459351

  • 1. A comparison of different formulations and dosage administrations of gemfibrozil.
    Kovanen PT, Koskinen P, Manninen V.
    Am J Cardiol; 1986 May 30; 57(14):31G-34G. PubMed ID: 3459351
    [Abstract] [Full Text] [Related]

  • 2. Gemfibrozil also corrects dyslipidemia in postmenopausal women and smokers.
    Koskinen P, Kovanen PT, Tuomilehto J, Manninen V.
    Arch Intern Med; 1992 Jan 30; 152(1):90-6. PubMed ID: 1728934
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of type III hyperlipoproteinemia with four different treatment regimens.
    Hoogwerf BJ, Bantle JP, Kuba K, Frantz ID, Hunninghake DB.
    Atherosclerosis; 1984 Jan 30; 51(2-3):251-9. PubMed ID: 6588975
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of gemfibrozil on levels of lipoprotein[a] in type II hyperlipoproteinemic subjects.
    Jones PH, Pownall HJ, Patsch W, Herd JA, Farmer JA, Payton-Ross C, Kimball KT, Gotto AM, Morrisett JD.
    J Lipid Res; 1996 Jun 30; 37(6):1298-308. PubMed ID: 8808764
    [Abstract] [Full Text] [Related]

  • 12. Apolipoprotein changes associated with the plasma lipid-regulating activity of gemfibrozil in cholesterol-fed rats.
    Krause BR, Newton RS.
    J Lipid Res; 1985 Aug 30; 26(8):940-9. PubMed ID: 3862732
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The Helsinki Heart Study: basic design and randomization procedure.
    Mänttäri M, Elo O, Frick MH, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P.
    Eur Heart J; 1987 Oct 30; 8 Suppl I():1-29. PubMed ID: 3322826
    [Abstract] [Full Text] [Related]

  • 17. Plasma prekallikrein, kallikrein inhibitors, kininogen and lipids during gemfibrozil treatment in type II dyslipidaemia.
    Torstila I, Kaukola S, Manninen V, Virtamo J, Mälkönen M.
    Acta Med Scand Suppl; 1982 Oct 30; 668():123-9. PubMed ID: 6188330
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of the hypolipidemic effect of gemfibrozil versus simvastatin in patients with type III hyperlipoproteinemia.
    Civeira F, Cenarro A, Ferrando J, Puzo J, Garcia-Otín AL, Mozas P, Pocoví M.
    Am Heart J; 1999 Jul 30; 138(1 Pt 1):156-62. PubMed ID: 10385780
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.